newsfilter
← Latest News
Business Wire·

Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer's Disease

Alpha Cognition Inc. (TSXV:ACOG) (OTCQB:ACOGF) ("Alpha Cognition," or the "Company"), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerative disorders, today announced positive results from a b